These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26605)

  • 1. The pharmacology of ergots: past and present.
    Lemberger L
    Fed Proc; 1978 Jun; 37(8):2176-80. PubMed ID: 26605
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum prolactin during aging and the effects of ergots.
    Clemens JA
    Adv Biochem Psychopharmacol; 1980; 23():315-21. PubMed ID: 6104911
    [No Abstract]   [Full Text] [Related]  

  • 3. Ergots and endocrine functions.
    Flückiger E
    Adv Biochem Psychopharmacol; 1980; 23():155-63. PubMed ID: 7395610
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The development of ergot alkaloids as drugs].
    Sinz A
    Pharm Unserer Zeit; 2008; 37(4):306-9. PubMed ID: 18618815
    [No Abstract]   [Full Text] [Related]  

  • 6. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminephilic properties of ergot alkaloids.
    Goldstein M; Lew JY; Nakamura S; Battista AF; Lieberman A; Fuxe K
    Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ergocornine on perphenazine-and oestrogen-induced prolactin release.
    Kulkarni PN; Simpson AA
    J Endocrinol; 1974 Oct; 63(1):35-41. PubMed ID: 4418486
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine profile of ergot alkaloids.
    Můller EE; Panerai AE; Cocchi D; Mantegazza P
    Life Sci; 1977 Dec; 21(11):1545-58. PubMed ID: 202827
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropharmacology of synthetic ergot derivatives in man.
    Lemberger L; Crabtree RE
    Adv Biochem Psychopharmacol; 1980; 23():117-24. PubMed ID: 6104905
    [No Abstract]   [Full Text] [Related]  

  • 12. Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors.
    Crider AM; Robinson JM; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1977 Nov; 20(11):1473-7. PubMed ID: 915908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prolactin secretion by ergot alkaloids.
    Nasr H; Pearson OH
    Acta Endocrinol (Copenh); 1975 Nov; 80(3):429-43. PubMed ID: 811032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison.
    Brooks CL; Welsch CW
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):863-7. PubMed ID: 4841203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological basis for the therapeutic use of ergot alkaloids].
    Tran MA; Montastruc JL; Montastruc P
    Presse Med; 1983 Feb; 12(8):517-20. PubMed ID: 6131414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure activity relationship and therapeutic uses of dopaminergic ergots.
    Markstein R; Seiler MP; Jaton A; Briner U
    Neurochem Int; 1992 Mar; 20 Suppl():211S-214S. PubMed ID: 1365428
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of isolated sheep umbilical cord blood vessels.
    Dyer DC
    J Pharmacol Exp Ther; 1970 Dec; 175(3):565-70. PubMed ID: 4395224
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
    Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of dorsal pedal vein of cattle to selected alkaloids associated with Acremonium coenophialum-infected fescue grass.
    Solomons RN; Oliver JW; Linnabary RD
    Am J Vet Res; 1989 Feb; 50(2):235-8. PubMed ID: 2719386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.